GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. Total Liabilities 2019–2025
GeneDx Holdings Corp. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- GeneDx Holdings Corp. total liabilities for the quarter ending December 31, 2025 were 215.5M, a 23.77% increase year-over-year.
- GeneDx Holdings Corp. total liabilities for 2025 were 215.5M, a 23.77% increase from 2024.
- GeneDx Holdings Corp. total liabilities for 2024 were 174.1M, a 8.71% decrease from 2023.
- GeneDx Holdings Corp. total liabilities for 2023 were 190.7M, a 19.60% decrease from 2022.
- GeneDx Holdings Corp. total liabilities for 2022 were 237.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| GeneDx Holdings Corp. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $216 |
| 2024 | $174 |
| 2023 | $191 |
| 2022 | $237 |
| 2021 | $166 |
| 2020 | $247 |
| GeneDx Holdings Corp. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $216 |
| 2024-12-31 | $174 |
| 2023-12-31 | $191 |
| 2022-12-31 | $237 |
| 2021-12-31 | $166 |
| 2020-12-31 | $247 |
GeneDx Holdings Corp. Total Liabilities — FAQ
GeneDx Holdings Corp. (WGS) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WGS's total liabilities history?
The chart and table above show GeneDx Holdings Corp.'s total liabilities by year and by quarter, including the growth rate.